Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TenofoBell in Chronic Hepatitis B
NCT04539652Phase 4Completed
- Sponsor
- Chong Kun Dang Holdings
- Start
- Sep 2018
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of TenofoBell in Chronic Hepatitis B (CHB), sponsored by Chong Kun Dang Holdings. Started Sep 2018; status: completed.
02
Drugs
TenofoBell
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT04539652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04539652.